Depletion of B lymphocytes from cerebral perivascular spaces by rituximab

Archives of Neurology

Volumn 66, Issue 8, 2009, Pages 1016-1020

  Martin, Maria Del Pilar ^a   Cravens, Petra D ^a   Winger, Ryan ^a   Kieseier, Bernd C ^d   Cepok, Sabine ^e   Eagar, Todd N ^a,b   Zamvil, Scott S ^f   Weber, Martin S ^e,f   Frohman, Elliot M ^a   Kleinschmidt DeMasters, Betty K ^g   Montine, Thomas J ^h   Hemmer, Bernhard ^e   Marra, Christina M ^h   Stüve, Olaf ^a,b,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; FLUDARABINE PHOSPHATE; RITUXIMAB;

AGED; ARTICLE; B LYMPHOCYTE; CASE REPORT; CEREBROSPINAL FLUID; CONFUSION; DRUG EFFECT; DRUG EFFICACY; FEMALE; FLOW CYTOMETRY; HOMONYMOUS HEMIANOPIA; HUMAN; HUMAN TISSUE; HYPESTHESIA; IMMUNOHISTOCHEMISTRY; JC VIRUS; LYMPHOCYTE DEPLETION; MANTLE CELL LYMPHOMA; MEMORY DISORDER; MULTIPLE CYCLE TREATMENT; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESIS; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REMISSION; TREATMENT OUTCOME; WHITE MATTER;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; B-LYMPHOCYTES; BASAL GANGLIA; BRAIN; CEREBRAL VENTRICLES; DOMINANCE, CEREBRAL; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; LYMPHOMA, MANTLE-CELL; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; MYELIN SHEATH; NEUROLOGIC EXAMINATION; SALVAGE THERAPY;

EID: 68549083770     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2009.157     Document Type: Article

References (22)

1. Valentine MA, Cotner T, Gaur L, Torres R, Clark EA. Expression of the human B-cell surface protein CD20: alteration by phorbol 12-myristate 13-acetate. Proc Natl Acad Sci U S A. 1987;84(22):8085-8089.
2. Pescovitz MD. Rituximab, an anti-CD20 monoclonal antibody: history and mechanism of action. Am J Transplant. 2006;6(5, pt 1):859-866.
3. Hauser SL, Waubant E, Arnold DL, et al; HERMES Trial Group. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med. 2008; 358(7):676-688.
4. Stüve O, Cepok S, Elias B, et al. Clinical stabilization and effective B-lymphocyte depletion in the cerebrospinal fluid and peripheral blood of a patient with fulminant relapsing-remitting multiple sclerosis. Arch Neurol. 2005;62(10):1620-1623.
5. Cross AH, Stark JL, Lauber J, Ramsbottom MJ, Lyons JA. Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients. J Neuroimmunol. 2006;180(1-2):63-70.
6. Binder M, Otto F, Mertelsmann R, Veelken H, Trepel M. The epitope recognized by rituximab. Blood. 2006;108(6):1975-1978.
7. Ruifrok AC, Johnston DA. Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol. 2001;23(4):291-299.
8. Ahuja A, Anderson SM, Khalil A, Shlomchik MJ. Maintenance of the plasma cell pool is independent of memory B cells. Proc Natl Acad Sci U S A. 2008;105 (12):4802-4807.
9. Anthony IC, Crawford DH, Bell JE. B lymphocytes in the normal brain: contrasts with HIV-associated lymphoid infiltrates and lymphomas. Brain. 2003;126(pt 5): 1058-1067.
10. Prineas JW, Wright RG. Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab Invest. 1978;38(4): 409-421.
11. Ozawa K, Suchanek G, Breitschopf H, et al. Patterns of oligodendroglia pathology in multiple sclerosis. Brain. 1994;117(pt 6):1311-1322.
12. Prayson RA, Frater JL. Rasmussen encephalitis: a clinicopathologic and immunohistochemical study of seven patients. Am J Clin Pathol. 2002;117(5):776-782.
13. Alvarez-Barón E, Bien CG, Schramm J, Elger CE, Becker AJ, Schoch S. Autoantibodies to Munc18, cerebral plasma cells and B-lymphocytes in Rasmussen encephalitis. Epilepsy Res. 2008;80(1):93-97.
14. del Pilar Martin M, Cravens PD, Winger R, et al. Decrease in the numbers of dendritic cells and CD4+T cells in cerebral perivascular spaces due to natalizumab. Arch Neurol. 2008;65(12):1596-1603.
15. Gonzalez H, Bolgert F, Camporo P, Leblond V. Progressive multifocal leukoencephalitis (PML) in three patients treated with standard-dose fludarabine (FAMP). Hematol Cell Ther. 1999;41(4):183-186.
16. Cid J, Revilla M, Cervera A, et al. Progressive multifocal leukoencephalopathy following oral fludarabine treatment of chronic lymphocytic leukemia. Ann Hematol. 2000;79(7):392-395.
17. Vidarsson B, Mosher DF, Salamat MS, Isaksson HJ, Onundarson PT. Progressive multifocal leukoencephalopathy after fludarabine therapy for low-grade lymphoproliferative disease. Am J Hematol. 2002;70(1):51-54.
18. Saumoy M, Castells G, Escoda L, Mares R, Richart C, Ugarriza A. Progressive multifocal leukoencephalopathy in chronic lymphocytic leukemia after treatment with fludarabine. Leuk Lymphoma. 2002;43(2):433-436.
19. Bonavita S, Conforti R, Russo A, et al. Infratentorial progressive multifocal leukoencephalopathy in a patient treated with fludarabine and rituximab. Neurol Sci. 2008;29(1):37-39.
20. Morgenstern LB, Pardo CA. Progressive multifocal leukoencephalopathy complicating treatment for Wegener's granulomatosis. J Rheumatol. 1995;22(8): 1593-1595.
21. Montillo M, Tedeschi A, O'Brien S, et al. Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia. Cancer. 2003;97(1):114-120.
22. Montoto S, Moreno C, Domingo-Doménech E, et al; Grup per l'Estudi dels Limfomes de Catalunya I Balears (GELCAB) Spain. High clinical and molecular response rates with fludarabine, cyclophosphamide and mitoxantrone in previously untreated patients with advanced stage follicular lymphoma. Haematologica. 2008;93(2):207-214.